Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation of Immune Persistence in a Phase III Clinical Trial of an Adsorbed Tetanus Vaccine

NCT07807033 is registered in ClinicalTrials.gov with CanSino Biologics Inc. as lead sponsor.

NCT NCT07807033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07807033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation of Immune Persistence in a Phase III Clinical Trial of an Adsorbed Tetanus Vaccine
Lead sponsor
CanSino Biologics Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
October 15, 2026
Completion date
November 15, 2026
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tetanus